{
    "clinical_study": {
        "@rank": "156376", 
        "acronym": "rTMS", 
        "arm_group": [
            {
                "arm_group_label": "Active rTMS1", 
                "arm_group_type": "Experimental", 
                "description": "Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex"
            }, 
            {
                "arm_group_label": "Active rTMS2", 
                "arm_group_type": "Experimental", 
                "description": "Temporal low frequency repetitive transcranial magnetic stimulation of left primary auditory cortex"
            }, 
            {
                "arm_group_label": "Active rTMS3", 
                "arm_group_type": "Experimental", 
                "description": "Frontal low frequency repetitive transcranial magnetic stimulation of left dorsolateral prefrontal cortex"
            }, 
            {
                "arm_group_label": "Sham rTMS4", 
                "arm_group_type": "Sham Comparator", 
                "description": "Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex"
            }
        ], 
        "brief_summary": {
            "textblock": "Efficacy of different protocols of transcranial magnetic stimulation for the treatment of\n      tinnitus"
        }, 
        "brief_title": "Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Tinnitus", 
        "condition_browse": {
            "mesh_term": "Tinnitus"
        }, 
        "detailed_description": {
            "textblock": "Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex\n      has an add-on effect for primary auditory cortex rTMS in improving tinnitus-related\n      distress. The investigators aimed to investigate whether rTMS of the dorsolateral prefrontal\n      cortex and primary auditory cortex are capable of reducing tinnitus loudness."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of chronic tinnitus\n\n          -  Chronic subjective tinnitus for more than 6 months\n\n          -  Subject is naive regarding rTMS\n\n          -  Other concurrent treatments: A four-week washout from any other tinnitus   treatment\n             or management program is required prior to entering this study\n\n          -  Stable enough to complete this study per the opinion of the Study Physician\n\n          -  No restrictions, provided the dosages have been in place for at least 3 months\n\n          -  A three month washout from any other tinnitus treatment or management program is\n             required prior to entering this study.\n\n        Exclusion Criteria:\n\n          -  Objective tinnitus or tinnitus with treatable cause\n\n          -  Presence of intracranial or intraocular ferromagnetic materiel or particles\n\n          -  Cardiac pacemaker or other electronic implants (including cochlear implant) Serious\n             heart disease or other unstable major medical condition\n\n          -  Personal history of central nervous system disorder, head injury, stroke or seizures\n\n          -  Familial history of epilepsy\n\n          -  Concomitant medication with antidepressants and antipsychotics\n\n          -  Pregnant women\n\n          -  Others known contraindications to rTMS or brain MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886092", 
            "org_study_id": "H-1212-081-451", 
            "secondary_id": "SNUHT1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active rTMS1", 
                "description": "repetitive transcranial magnetic stimulation (Figured 8-Coil Cool-B65): 1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects).", 
                "intervention_name": "repetitive transcranial magnetic stimulation (rTMS) 1", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Active rTMS2", 
                "description": "repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left temporal cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects)", 
                "intervention_name": "repetitive transcranial magnetic stimulation (rTMS) 2", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Active rTMS3", 
                "description": "repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) each consisting of 4 days of rTMS treatment. (20 subjects)", 
                "intervention_name": "repetitive transcranial magnetic stimulation (rTMS) 3", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham rTMS4", 
                "description": "Sham rTMS, applied with the same combination of parameters as active rTMS, except for the number of stimulations per session. (20 subjects)", 
                "intervention_name": "sham repetitive transcranial magnetic stimulation (rTMS) 4", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "tinnitus", 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "contact": {
                "last_name": "Oh", 
                "phone": "02-2072-2114"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Lee, MD ph,D", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus", 
        "overall_contact": {
            "email": "drmung@naver.com", 
            "last_name": "Tae-Soo Noh, BS", 
            "phone": "82-2-2072-2447"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Myung-Whan Suh, MD, ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change of tinnitus severity as measured by the visual analogue scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in visual analogue scale at 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886092"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Beck's Depression Inventory (BDI)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention"
            }, 
            {
                "measure": "State-Trait Anxiety Inventory (STAI)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention"
            }, 
            {
                "measure": "Pittsburgh Sleep Quality Index (PSQI)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention"
            }, 
            {
                "measure": "Tinnitus Handicap Inventory (THI)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, day 3, day 7, day 14, 1, 2 and 3 months after the first intervention"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}